Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis.
Takanori MukozuHidenari NagaiDaigo MatsuiKunihide MohriGo WatanabeNaoyuki YoshimineMakoto AmanumaKojiro KobayashiYu OginoYasushi MatsukiyoTeppei MatsuiYasuko DaidoNoritaka WakuiMie ShinoharaKoichi MomiyamaKoji HigaiYoshinori IgarashiPublished in: Cancer chemotherapy and pharmacology (2021)
Lenvatinib treatment should be avoided in patients with Vp4 with a high degree of portal trunk occlusion because of concerns about decreased portal blood flow.
Keyphrases